DLBCL Cell Line Culture and Drug Treatment
Variable analysis
- PRT062607
- Dasatinib
- BYL719
- CAL-101
- IPI-145
- TGX221
- CZC24832
- Cell growth and proliferation
- RPMI 1640 plus 20% FBS plus Pen/Strep medium for ABC DLBCL lines TMD8, HBL1, OYB, U2932, SUDHL2, and TK, and GCB-DLBCL lines BJAB, OCI-Ly1, and OCI-Ly8
- RPMI 1640 plus 20% heparinized human plasma plus Pen/Strep medium for ABC DLBCL lines OCI-Ly10, OCI-Ly3 and DLBCL2
- Cell lines previously engineered to express an ecotropic retroviral receptor and a bacterial tetracycline repressor
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!